4.4 Article

A case of cerebrotendinous xanthomatosis with brain and spinal involvement without tendon xanthomas: Identification of a novel mutation of the CYP27A1 gene

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Update on cerebrotendinous xanthomatosis

Andrea E. DeBarber et al.

Summary: Cerebrotendinous xanthomatosis (CTX) is a rare genetic disorder with highly variable clinical presentation. Early diagnosis and treatment are crucial for better outcomes. New diagnostic algorithms, screening strategies, and improved biochemical testing contribute to enhanced diagnosis and evaluation of treatment efficacy.

CURRENT OPINION IN LIPIDOLOGY (2021)

Article Pharmacology & Pharmacy

Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosis

P. Barton Duell et al.

JOURNAL OF CLINICAL LIPIDOLOGY (2018)

Article Genetics & Heredity

Nationwide survey on cerebrotendinous xanthomatosis in Japan

Yoshiki Sekijima et al.

JOURNAL OF HUMAN GENETICS (2018)

Article Clinical Neurology

Different phenotypes in identical twins with cerebrotendinous xanthomatosis: case series

Denes Zadori et al.

NEUROLOGICAL SCIENCES (2017)

Review Endocrinology & Metabolism

Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX)

Gerald Salen et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2017)

Article Endocrinology & Metabolism

Apparent underdiagnosis of Cerebrotendinous Xanthomatosis revealed by analysis of ∼60,000 human exomes

Vivek Appadurai et al.

MOLECULAR GENETICS AND METABOLISM (2015)

Article Endocrinology & Metabolism

A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis

Andrea Mignarri et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2014)